Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Cri
(eBook)
In this book, Stefan Pieper supports doctors and therapists in easily diagnosing FQAD and in better and more adequately dealing with FQAD patients. Fluoroquinolones, as one of the most common and effective groups of antibiotics, are known to have a distinct spectrum of side effects. These adverse effects are rare in percentage terms, but frequent in absolute numbers due to the enormous quantities of prescriptions. Because they are usually quite severe and wide-ranging, they tend to run like a syndrome and have been classified by the FDA as a separate condition, the FQAD, because of their frequency, severity and risk of disability. This book presents for the first time a comprehensive description and classification of the clinical picture and a proposal for a clinical diagnostic tool based on diagnostic criteria.
Notes
Pieper, S. (2021). Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Cri. [United States], Springer International Publishing|Springer International Publishing.
Chicago / Turabian - Author Date Citation (style guide)Pieper, Stefan. 2021. Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Cri. [United States], Springer International Publishing|Springer International Publishing.
Chicago / Turabian - Humanities Citation (style guide)Pieper, Stefan, Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Cri. [United States], Springer International Publishing|Springer International Publishing, 2021.
MLA Citation (style guide)Pieper, Stefan. Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Cri. [United States], Springer International Publishing|Springer International Publishing, 2021.
Hoopla Extract Information
hooplaId | 15166851 |
---|---|
title | Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Cri |
kind | EBOOK |
price | 2.69 |
active | 1 |
pa | 0 |
profanity | 0 |
children | 0 |
demo | 0 |
rating | |
abridged | 0 |
dateLastUpdated | Jan 26, 2024 06:14:10 PM |
Record Information
Last File Modification Time | Nov 22, 2023 11:40:02 PM |
---|---|
Last Grouped Work Modification Time | Jan 26, 2024 03:04:47 PM |
MARC Record
LEADER | 02416nam a22004095a 4500 | ||
---|---|---|---|
001 | MWT15166851 | ||
003 | MWT | ||
005 | 20231027102159.0 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 231027s2021 xxu eo 000 0 eng d | ||
020 | |a 9783030741730|q (electronic bk.) | ||
020 | |a 3030741737|q (electronic bk.) | ||
028 | 4 | 2 | |a MWT15166851 |
029 | |a https://d2snwnmzyr8jue.cloudfront.net/csp_9783030741730_180.jpeg | ||
037 | |a 15166851|b Midwest Tape, LLC|n http://www.midwesttapes.com | ||
040 | |a Midwest|e rda | ||
099 | |a eBook hoopla | ||
100 | 1 | |a Pieper, Stefan,|e author. | |
245 | 1 | 0 | |a Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Cri|h [electronic resource] /|c Stefan Pieper. |
264 | 1 | |a [United States] :|b Springer International Publishing|Springer International Publishing,|c 2021. | |
264 | 2 | |b Made available through hoopla | |
300 | |a 1 online resource | ||
336 | |a text|b txt|2 rdacontent | ||
337 | |a computer|b c|2 rdamedia | ||
338 | |a online resource|b cr|2 rdacarrier | ||
347 | |a text file|2 rda | ||
506 | |a Instant title available through hoopla. | ||
520 | |a In this book, Stefan Pieper supports doctors and therapists in easily diagnosing FQAD and in better and more adequately dealing with FQAD patients. Fluoroquinolones, as one of the most common and effective groups of antibiotics, are known to have a distinct spectrum of side effects. These adverse effects are rare in percentage terms, but frequent in absolute numbers due to the enormous quantities of prescriptions. Because they are usually quite severe and wide-ranging, they tend to run like a syndrome and have been classified by the FDA as a separate condition, the FQAD, because of their frequency, severity and risk of disability. This book presents for the first time a comprehensive description and classification of the clinical picture and a proposal for a clinical diagnostic tool based on diagnostic criteria. | ||
538 | |a Mode of access: World Wide Web. | ||
650 | 0 | |a Critical care medicine. | |
650 | 0 | |a Family medicine. | |
650 | 0 | |a Internal medicine. | |
650 | 0 | |a Electronic books. | |
710 | 2 | |a hoopla digital. | |
856 | 4 | 0 | |u https://www.hoopladigital.com/title/15166851?utm_source=MARC&Lid=hh4435|z Instantly available on hoopla. |
856 | 4 | 2 | |z Cover image|u https://d2snwnmzyr8jue.cloudfront.net/csp_9783030741730_180.jpeg |